Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Rituximab: Don't Count It Out as MS Treatment
Multiple sclerosis.
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
Effect of Genzyme’s LEMTRADA™ maintained in patients beyond two-year pivotal MS studies
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.

Pages